Bryophyllum Avena
Generic Name: bryophyllum avena
Brand Names:
Bryophyllum Avena
Uses: Temporary relief of sleeplessness or nervous tension.
Overview
Uses: Temporary relief of sleeplessness or nervous tension.
Uses
Directions: FOR ORAL USE ONLY.
Dosage
Take 3-4 times daily. Ages 12 and older: 10 drops. Ages 2-11: 5 drops. Under age 2: Consult a doctor.
Warnings
Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Do not use if allergic to any ingredient. Contains traces of lactose. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing. REFRIGERATE AFTER OPENING. BEST WHEN USED WITHIN 30 DAYS OF OPENING. SHAKE WELL BEFORE USE.
Frequently Asked Questions
What is Bryophyllum Avena used for?▼
Directions: FOR ORAL USE ONLY.
What are the important warnings for Bryophyllum Avena?▼
Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Do not use if allergic to any ingredient. Contains traces of lactose. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing. REFRIGERATE AFTER OPENING. BEST WHEN USED WITHIN 30 DAYS OF OPENING. SHAKE WELL BEFORE USE.
Related Medications
Maraviroc
maraviroc
CCR5 Co-receptor Antagonist [EPC]
11 DESCRIPTION Maraviroc is a selective, slowly reversible, small molecule antagonist of the interaction between human CCR5 and HIV-1 gp120. Blocking this interaction prevents CCR5-tropic HIV-1 entry into cells. Maraviroc film-coated tablets for oral administration contain 150, or 300 mg of maraviroc and the following inactive ingredients: anhydrous dibasic calcium phosphate, hydroxypropyl methyl cellulose, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate.
Incobotulinumtoxina
incobotulinumtoxina
Acetylcholine Release Inhibitor [EPC]
11 DESCRIPTION The active ingredient of XEOMIN is botulinum toxin type A produced from fermentation of Hall strain Clostridium botulinum serotype A. The botulinum toxin complex is purified from the culture supernatant and then the active ingredient is separated from the proteins (hemagglutinins and non-hemagglutinins) through a series of steps yielding the active neurotoxin with molecular weight of 150 kDa, without accessory proteins.
Dock Yellow
dock yellow
Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: RUMEX CRISPUS POLLEN (.1 g/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.